Bupivacaine Hydrochloride Injection, Solution
Product Images NDC 0143-9328

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Bupivacaine Hydrochloride (NDC 0143-9328). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bupivacaine Hydrochloride Structure (Bupivacaine Hydrochloride Injection Usp Multiple D 1)

Chemical structure diagram of Bupivacaine Hydrochloride, showing its molecular components including the piperidine ring, amide linkage, aromatic ring with methyl substituents, and the associated hydrochloride and water molecules.*

FDA Label Image

9328-01 (Bupivacaine Hydrochloride Injection Usp Multiple D 2)

Label for Bupivacaine Hydrochloride Injection, USP 0.25%, 125 mg per 50 mL (2.5 mg/mL) solution for injection by perineural route. It is a 50 mL multiple-dose vial labeled for infiltration and nerve block, specifying it is not for caudal, epidural, or spinal anesthesia. The label includes storage temperature instructions and is from Hikma Pharmaceuticals USA Inc.*

FDA Label Image

9328-10 (Bupivacaine Hydrochloride Injection Usp Multiple D 3)

Label for Bupivacaine HCl Injection, USP 0.25% (2.5 mg/mL) by Hikma Pharmaceuticals USA Inc. The label states 125 mg per 50 mL in a multiple-dose vial. It is indicated for infiltration and nerve block, with a warning against use for caudal, epidural, or spinal anesthesia. Preservative added, sterile and nonpyrogenic solution. Includes storage instructions and manufacturer details.*

FDA Label Image

9329-01 (Bupivacaine Hydrochloride Injection Usp Multiple D 4)

Bupivacaine Hydrochloride 5 mg/mL injection solution label on a 50 mL multiple-dose vial. The label specifies a total of 250 mg per 50 mL, intended for perineural use such as nerve blocks. It includes warnings against use for caudal, epidural, or spinal anesthesia. The product is labeled by Hikma Pharmaceuticals USA Inc. with additional details on storage, dosage, and preservative content.*

FDA Label Image

9329-10 (Bupivacaine Hydrochloride Injection Usp Multiple D 5)

Label for Bupivacaine Hydrochloride Injection, USP 0.5% (5 mg/mL), indicating 250 mg per 50 mL in 10 x 50 mL multiple-dose vials. It is intended for nerve block use, not for caudal, epidural, or spinal anesthesia. Manufactured by Hikma Farmacêutica (Portugal), distributed by Hikma Pharmaceuticals USA Inc., with preservation and storage instructions included.*

FDA Label Image

Representative Serialization Image (Bupivacaine Hydrochloride Injection Usp Multiple D 6)

A label section showing a QR code alongside printed text with a Global Trade Item Number (GTIN), serial number (SN), expiration date (EXP) 12/2099, and lot number (LOT). The label is from Bupivacaine Hydrochloride injection solution, 2.5 mg/mL or 5 mg/mL, by Hikma Pharmaceuticals USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.